PT Bifarma Adiluhung

PT Bifarma Adiluhung is a leading Indonesian biotechnology company and a subsidiary of PT Kalbe Farma Tbk, the largest pharmaceutical group in Southeast Asia. The company specializes in the development, manufacturing, and commercialization of advanced biopharmaceuticals, including biosimilars, cell therapies, and molecular diagnostics. Bifarma Adiluhung operates a state-of-the-art GMP-certified facility in Jakarta, which was the first of its kind in Indonesia for biologics production. Through its Regenic brand, the company provides innovative regenerative medicine solutions such as stem cell treatments for osteoarthritis. Additionally, the company collaborates with international partners like Genexine to bring novel therapies, such as long-acting erythropoietin, to the regional market. Its business model encompasses both proprietary product development and contract manufacturing services for the life sciences sector.